| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Despite progress in the prevention and treatment of HIV, persistent
issues concerning the evaluation of continuum in care from the
serological diagnosis to virologic success remains. Considering the
2020 UNAIDS target 90-90-90 for diagnosis, treatment, and viral
suppression of people living with HIV (PLWH), our purpose was to verify
if, starting from new diagnoses, the viral suppression rate of our
cohort of new PLWH satisfied the second and the third steps.
Materials and Methods
|Table 1. Achievement of second UNAIDS Target (start of ART). Demographic characteristics of new diagnoses, of treated and not treated PLWH.|
|Table 2. Achievement of third UNAIDS Target (viral suppression). Demographic and immunological characteristics of patients who started ART.|
|Figure 1. The cascade of continuum in care from diagnoses to viral suppression at 24 months. Legend: ART: antiretroviral therapy.|
|Figure 2. The 2020 UNAIDS 90 targets for treatment and viral suppression, expected vs observed in the study population.|